Notice and Copy of Sublicense. Within thirty (30) days of execution of each Sublicense, or amendment thereof, Licensee will notify ULRF of such executed Sublicense or amendment and provide to ULRF a copy of such Sublicense or amendment with no portion which is relevant to ULRF’s rights hereunder redacted. Such Sublicense or amendment shall be Confidential Information of Licensee hereunder.
Appears in 3 contracts
Samples: Exclusive License Agreement (Qualigen Therapeutics, Inc.), Exclusive License Agreement (Qualigen Therapeutics, Inc.), Exclusive License Agreement (Ritter Pharmaceuticals Inc)
Notice and Copy of Sublicense. Within thirty (30) days of execution of each Sublicense, or amendment thereof, Licensee will notify ULRF of such executed Sublicense or amendment and provide to ULRF a copy of such Sublicense or amendment with no portion which is relevant amendment; provided, however, that Licensee shall have the right to ULRF’s rights hereunder redacted. Such redact parts of such Sublicense or amendment shall be Confidential Information of Licensee hereunderto the extent such parts are not necessary to determine Licensee’s compliance with this Agreement.
Appears in 2 contracts
Samples: Exclusive License Agreement (Talaris Therapeutics, Inc.), Exclusive License Agreement (Talaris Therapeutics, Inc.)
